Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions

por Reichart, Deborah L, Hinkle, Richard T, Lefever, Frank R, Dolan, Elizabeth T, Dietrich, Jeffrey A, Sibley, David R, Isfort, Robert J
Publicado 2011

Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals

por Hinkle, Richard T, Lefever, Frank R, Dolan, Elizabeth T, Reichart, Deborah L, Zwolshen, Janice M, Oneill, Timothy P, Maloney, Kris G, Mattson, John P, Ferreira, Leonardo F, Musch, Timothy I, Poole, David C, Isfort, Robert J
Publicado 2011

Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice

por Hinkle, Richard T, Lefever, Frank R, Dolan, Elizabeth T, Reichart, Deborah L, Dietrich, Jefferey A, Gropp, Kathryn E, Thacker, Robert I, Demuth, Jeffrey P, Stevens, Paula J, Qu, Xiaoyan A, Varbanov, Alex R, Wang, Feng, Isfort, Robert J
Publicado 2007